Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer
Apply
177Lu-CYT-500
Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step